-
-
-
-
-
-
-
BTIG Downgrades Insulet Corporation (PODD) to Neutral
-
-
-
-
-
-
-
RBC sees over 80% upside to its price target for this medical stock
-
-
-
-
-
-
-
Insulet beats revenue expectations in fourth quarter, shares rise
-
-
-
-
-
-
-
Buy this stock into tomorrow's Analyst Day: UBS
-
-
-
-
-
-
-
Insulet (PODD) Tops Q2 EPS by 25c
-
-
-
-
-
-
-
Insulet (PODD) Appoints Ashley McEvoy as President and CEO
-
-
-
-
-
-
-
Insulet Corporation (PODD) PT Raised to $283 at Citi
-
1,230,272 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


